序号 |
标题 |
次数 |
作者 |
发布时间 |
71506 |
mPEG44-OCH2COOH的介绍 |
100 |
zyl |
2024-12-24 |
71507 |
5-对-(对羰基苯甲酸)-氨基苯基-10,15,20-三苯基卟啉锌(Ⅱ)Zn(p-CPTPP) |
107 |
WYQ |
2024-12-24 |
71508 |
1189194-65-7,DOTA-CH2-Alkynyl (TFA salt),大环化合物 |
74 |
kx |
2024-12-24 |
71509 |
Alendronate Liposome (Anionic) 阿仑膦酸盐脂质体(阴离子) |
112 |
axc |
2024-12-24 |
71510 |
meso-四(4-甲基-3-磺酸苯基)卟啉[简称T(4-MP)PS4] |
127 |
WYQ |
2024-12-24 |
71511 |
mPEG9-OCH2COOH的结构式 |
97 |
zyl |
2024-12-24 |
71512 |
SPDMB,2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,2101206-29-3,抗体- 药物偶联物 |
115 |
hyy |
2024-12-24 |
71513 |
PAMAM-DOTA-Gd,大环化合物 |
66 |
kx |
2024-12-24 |
71514 |
四(4-溴苯基)卟啉银(AgTBrPP),AgTBrPP是一种含银的金属卟啉配合物。 |
124 |
WYQ |
2024-12-24 |
71515 |
mPEG36-NH-Mal 甲氧基三十六聚乙二醇-NH-马来酰亚胺 |
136 |
zyl |
2024-12-24 |
71516 |
DOTA-TATE,177943-88-3,大环化合物 |
100 |
kx |
2024-12-24 |
71517 |
meso-四(3-氯苯基)卟啉(T(3-C1P)P) |
85 |
WYQ |
2024-12-24 |
71518 |
mPEG48-OCH2CH2COOH cas:125220-94-2 |
126 |
zyl |
2024-12-24 |
71519 |
对照阿仑膦酸盐脂质体(中性),Control Alendronate Liposome (Neutral) |
83 |
axc |
2024-12-24 |
71520 |
甲基丙烯酸十二烷氧基四苯基卟啉(MM-TPP-12C) |
77 |
WYQ |
2024-12-24 |
71521 |
mPEG36-OH cas:2633587-48-9 cas:114740-40-8 甲氧基三十六聚乙二醇-羟基 |
137 |
zyl |
2024-12-24 |
71522 |
DOTA-(酪氨酸3)-奥曲肽,204318-14-9,DOTA-TOC,大环化合物 |
65 |
kx |
2024-12-24 |
71523 |
Alendronate Liposome (Neutral),阿仑膦酸盐脂质体(中性) |
104 |
axc |
2024-12-24 |
71524 |
meso-四(3-氯苯基)卟啉(T(3-C1P)P),T(3-C1P)P |
124 |
WYQ |
2024-12-24 |
71525 |
DOTA-(酪氨酸3)-奥曲肽,204318-14-9,大环化合物 |
107 |
kx |
2024-12-24 |
71526 |
mPEG6-Hydrazide 甲氧基六聚乙二醇-酰肼 |
83 |
zyl |
2024-12-24 |
71527 |
小檗碱脂质体,Berberine Liposome |
115 |
axc |
2024-12-24 |
71528 |
2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate,107348-47-0,ADC试剂 |
79 |
hyy |
2024-12-24 |
71529 |
甲基丙烯酸十二烷氧基四苯基卟啉(MM-TPP-12C) |
165 |
WYQ |
2024-12-24 |
71530 |
mPEG16-N3 cas:89485-61-0 甲氧基十六聚乙二醇-叠氮 |
85 |
zyl |
2024-12-24 |
71531 |
DOTA-Mal,1006711-90-5,大环化合物 |
117 |
kx |
2024-12-24 |
71532 |
盐酸博安霉素脂质体,Boanmycin Hydrochloride Liposome |
82 |
axc |
2024-12-24 |
71533 |
金属离子螯合剂DOTA-NOC ,CAS:619300-53-7 |
139 |
kx |
2024-12-24 |
71534 |
mPEG8-巯基 cas:651042-83-0 甲氧基八聚乙二醇-巯基 |
93 |
zyl |
2024-12-24 |
71535 |
拉科酰胺脂质体,Lacosamide Liposome |
65 |
axc |
2024-12-24 |
71536 |
perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate,160580-70-1 ,抗体- 药物偶联物 |
179 |
hyy |
2024-12-24 |
71537 |
DOTA-NHS ester,170908-81-3,DOTA活性酯 |
79 |
kx |
2024-12-24 |
71538 |
四(对-辛酰氧基)苯基叶啉锰[简称T(p-OO)PPMn] |
139 |
WYQ |
2024-12-24 |
71539 |
mPEG16-巯基 cas:874820-38-9 甲氧基十六聚乙二醇-巯基 |
77 |
zyl |
2024-12-24 |
71540 |
Breviscapine Liposome,灯盏花素脂质体 |
92 |
axc |
2024-12-24 |
71541 |
C13-R8,大环化合物 |
94 |
kx |
2024-12-24 |
71542 |
mPEG12-OCH2CH2COOH cas:2170098-33-4 |
175 |
zyl |
2024-12-24 |
71543 |
DOTA-C4-NH2 ,753421-63-5,1,4,7,10-四氮杂环十二烷-1,4,7-三(乙酸)-10(4-氨基丁基)乙酰胺 |
91 |
kx |
2024-12-24 |
71544 |
四碘化5,10,15,20-四(对-N,N,N-三甲基苯胺基)卟啉(TAPPI) |
98 |
WYQ |
2024-12-24 |
71545 |
西罗莫司脂质体,Sirolimus Liposome |
98 |
axc |
2024-12-24 |
71546 |
mPEG7-OCH2CH2COOH cas:1093647-41-6 |
85 |
zyl |
2024-12-24 |
71547 |
七肽DOTA-YLYEIAR,1262403-91-7,螯合物前体肽 |
76 |
kx |
2024-12-24 |
71548 |
N-Succinimidyl 3-(pyridin-2-yldithio)-propionate (SPDP),68181‐17‐9,ADC试剂 |
79 |
hyy |
2024-12-24 |
71549 |
5-(4-羧基苯基)-10,15,20-三苯基卟啉(CTPP) |
106 |
WYQ |
2024-12-24 |
71550 |
mPEG24-OH cas:2376450-73-4 甲氧基二十四聚乙二醇-羟基 |
130 |
zyl |
2024-12-24 |